EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer.
Wang CQ, Li Y, Huang BF, Zhao YM, Yuan H, Guo D, Su CM, Hu GN, Wang Q, Long T, Wang Y, Tang CH, Li X.
Wang CQ, et al.
Sci Rep. 2017 Nov 15;7(1):15654. doi: 10.1038/s41598-017-15939-9.
Sci Rep. 2017.
PMID: 29142206
Free PMC article.